Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
新型脾酪氨酸激酶抑制剂兰拉普利尼在狼疮性肾炎模型中的作用机制表征
期刊:BMC Rheumatology
影响因子:2.1
doi:10.1186/s41927-021-00178-3
Christopher W Pohlmeyer, Ching Shang, Pei Han, Zhi-Hua Cui, Randall M Jones, Astrid S Clarke, Bernard P Murray, David A Lopez, David W Newstrom, M David Inzunza, Franziska G Matzkies, Kevin S Currie, Julie A Di Paolo